Icosagen Group

About:

Icosagen Group is a contract research provider and technology developer for biopharmaceutical and biotechnology industries and academia.

Website: http://icosagen.com

Top Investors: European Investment Bank, EASME - EU Executive Agency for SMEs

Description:

Icosagen Group is a contract research provider and technology developer for biopharmaceutical and biotechnology industries and academia that offers high-end biotechnology services and products. The company’s services include protein production, antibody production, and VLP production. Its products include antibodies, proteins, ELISA kits, transfection reagent, and DNA/RNA isolation. It also offers quality control services such as food microbiology testing services and FITkit for latex allergen testing. Icosagen Group participates in several international and national research programs and projects, including INTENSO, MAARS, and EURIPRED. Its QMCF Technology is a stable episomal expression system that uses specific mammalian cells and appropriate vectors for production of secretable and intracellular recombinant proteins, antibodies, virus-like particles; and for expression of intracellular proteins at physiologically relevant level for development of cell-based assays for screening purposes. The Group is comprised of three entities: parent company Icosagen AS and two subsidiaries: Icosagen Cell Factory Ltd and IcoPark Ltd. Icosagen Group is based in Tartumaa, Estonia.